A substrate-driven allosteric switch that enhances PDI catalytic activity
Protein disulfide isomerase (PDI) is an oxidoreductase essential for folding proteins in the endoplasmic reticulum. The domain structure of PDI is a – b – b′ – x – a′ , wherein the thioredoxin-like a and a′ domains mediate disulfide bond shuffling and b and b′ domains are substrate binding. The b′ a...
Saved in:
Published in: | Nature communications Vol. 7; no. 1; pp. 12579 - 11 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
30-08-2016
Nature Publishing Group Nature Portfolio |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Protein disulfide isomerase (PDI) is an oxidoreductase essential for folding proteins in the endoplasmic reticulum. The domain structure of PDI is
a
–
b
–
b′
–
x
–
a′
, wherein the thioredoxin-like
a
and
a′
domains mediate disulfide bond shuffling and
b
and
b′
domains are substrate binding. The
b′
and
a′
domains are connected via the x-linker, a 19-amino-acid flexible peptide. Here we identify a class of compounds, termed bepristats, that target the substrate-binding pocket of
b′
. Bepristats reversibly block substrate binding and inhibit platelet aggregation and thrombus formation
in vivo
. Ligation of the substrate-binding pocket by bepristats paradoxically enhances catalytic activity of
a
and
a′
by displacing the x-linker, which acts as an allosteric switch to augment reductase activity in the catalytic domains. This substrate-driven allosteric switch is also activated by peptides and proteins and is present in other thiol isomerases. Our results demonstrate a mechanism whereby binding of a substrate to thiol isomerases enhances catalytic activity of remote domains.
Protein Disulfide Isomerase (PDI) is a prothrombotic, multidomain enzyme with separate substrate binding and catalytic domains. Here, the authors identify a new class of compounds that target the PDI substrate binding site, inducing a conformational change in the catalytic domains and inhibiting thrombosis. |
---|---|
Bibliography: | National Institute on Drug Abuse (NIDA) USDOE Office of Science (SC) Hemostasis and Thrombosis Research Society AC02-05CH11231; U54 HL112302; R01 HL125275; R01 HL112809; T32 HL007917; T32 HL16324-02; HL116324; DA032476; U54 HG005032 National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) NIH Molecular Libraries Probe Production Centers Network (MLPCN) |
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/ncomms12579 |